Publications (22) Publications in which a researcher has participated View referenced research data.

filter_list Cancer Research

2024

  1. Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3

    Histology and histopathology, Vol. 39, Núm. 1, pp. 35-40

  2. Effect of Tumor Regression Grade on Survival and Disease-Free Interval in Patients Operated on for Locally Advanced Rectal Cancer

    Cancers, Vol. 16, Núm. 10

  3. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice

    Medicina (Lithuania), Vol. 60, Núm. 1

  4. Histone Acetyl Transferase 1 Is Overexpressed in Poor Prognosis, High-grade Meningeal and Glial Brain Cancers: Immunohistochemical and Aptahistochemical Study

    Journal of Histochemistry and Cytochemistry, Vol. 72, Núm. 8-9, pp. 585-599

  5. PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications

    Journal of Molecular Medicine, Vol. 102, Núm. 8, pp. 987-1000

  6. Prognostic Value of Histone Acetyl Transferase 1 (HAT-1) and Inflammatory Signatures in Pancreatic Cancer

    Current Issues in Molecular Biology, Vol. 46, Núm. 5, pp. 3839-3865

  7. Prognostic Value of Tumor Deposits in Patients with Colorectal Cancer

    Journal of Cancer, Vol. 15, Núm. 15, pp. 4789-4800

  8. Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a Snail/ERK dependent mechanism

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 1

2023

  1. An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  2. Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  3. Clinical and Translational Applications of Serological and Histopathological Biomarkers in Metastatic Breast Cancer: A Comprehensive Review

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

  4. Correlation Between Endoglin and Malignant Phenotype in Human Melanoma Cells: Analysis of hsa-mir-214 and hsa-mir-370 in Cells and Their Extracellular Vesicles

    Advances in experimental medicine and biology, Vol. 1408, pp. 253-272

  5. Is Insulin Receptor Substrate4 (IRS4) a Platform Involved in the Activation of Several Oncogenes?

    Cancers, Vol. 15, Núm. 18

  6. Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer

    Cancers, Vol. 15, Núm. 1

  7. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer

    Journal of Personalized Medicine, Vol. 13, Núm. 2

2022

  1. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer

    Antioxidants, Vol. 11, Núm. 4

  2. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer

    Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459

2021

  1. Downregulation of snail by dusp1 impairs cell migration and invasion through the inactivation of jnk and erk and is useful as a predictive factor in the prognosis of prostate cancer

    Cancers, Vol. 13, Núm. 5, pp. 1-21

  2. Thyroid Hormone Receptors and their Role in Cell Proliferation and Cancer

    Cellular Endocrinology in Health and Disease, Second Edition (Elsevier), pp. 229-246

2020

  1. Complete loss of epcam immunoexpression identifies epcam deletion carriers in msh2negative colorectal neoplasia

    Cancers, Vol. 12, Núm. 10, pp. 1-20